A platform for mechanistic modelling of subcutaneous administration with the effect of immunogenicity within the Open Systems Pharmacology framework

PAGE 30 (2022) Abstr 10129
Pellowe M, Eriksson J, Chenel M, Sjögren E.
ConferenceImmunologyPBPK/PBBMQSP

Pharmetheus Affiliates

Portrait-of-Moriah-Pellowe_Pharmetheus
Director, MIDD Consultant

Moriah Pellowe

See bio
Portrait-of-Johanna-Eriksson_Pharmetheus
Senior Director, MIDD Consultant

Johanna Eriksson

See bio
Portrait-of-Erik-Sjogren_Pharmetheus-2
Principal Director, PBPK & PBBM Scientific Lead

Erik Sjögren

See bio
Portrait-of-Marylore-Chenel_Pharmetheus
Chief Research Officer

Marylore Chenel

See bio